BofA Global Research raises Regeneron price objective to $908 from $891
REGN•BofA Global Research raised its price objective for Regeneron Pharmaceuticals to $908 from $891.
Related News
TPG Inc: TD Cowen cuts target price to $60 from $64
TPG•
UBS trims Wienerberger voting rights to 3.96% from 4.09%
UBS•
Rexford Industrial Realty target price raised to $39 from $38 by Truist Securities
REXR•
Permian Resources target price raised by Truist Securities to $28 from $24
PR•
Blue Owl Capital raises target price to $16 from $15
OWL•